HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 P24 ANTIGEN IN CERVICOVAGINAL SECRETIONS

被引：7

作者：

BELEC, L

MATTA, M

PAYAN, C

GRESENGUET, G

TEVIBENISSAN, C

PILLOT, J

机构：

[1] HOP BROUSSAIS,SERV MICROBIOL VIROL,PARIS,FRANCE

[2] CTR NATL REFERENCE MALAD SEXUELLEMENT TRANSMISSIB,BANGUI,CENT AFR REPUBL

来源：

JOURNAL OF INFECTIOUS DISEASES | 1995年 / 171卷 / 06期

关键词：

D O I：

10.1093/infdis/171.6.1615

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The failure to detect human immunodeficiency virus (HIV) antigen in cervicovaginal secretions (CVS) from HIV-infected women could be due in part to an in situ formation of immune complexes involving HIV antigens and cervicovaginal anti-HIV antibodies, CVS from 30 HIV-1-infected heterosexual women were assayed for p24 antigen detection by ELISA before and after acid disruption of immune complexes, Before acid treatment, free p24 antigen was detected in only 1 sample of CVS, whereas after acid dissociation, 4 (13.5%) of 30 samples had detectable and neutralizable p24 antigen, Adsorbent capacities of the CVS for recombinant p24 antigen, evaluated in an in vitro model, depended on both titer and avidity of cervicovaginal antibodies to HIV. In conclusion, local antibodies to HIV are able in vivo to bind HIV antigen within CVS and to participate in the immune exclusion of free virus particles or proteins.

引用

页码：1615 / 1618

页数：4

共 15 条

[1]

Henin Y., Mandelbrot L., Henrion R., Pradinaud R., Coulaud J.P., Montagnier L., Virus excretion in the cervicovaginal secretions of pregnant and non pregnant hiv-infected women, J Acquir Immune De Fic Syndr, 6, pp. 72-75, (1993)

[2]

Kreiss J., Willerford D.M., Hensel M., Et al., Association between cervical inflammation and cervical shedding of human immunodeficiency virus dna, J Infect Dis, 170, pp. 1597-1601, (1994)

[3]

Homsy J., Thomson-Honnebier G.A., Cheng-Mayer C., Levy J.A., Detection of human immunodeficiency virus (Hiv) in serum and body fluids by sequential competition elisa, J Virol Methods, 19, pp. 43-56, (1988)

[4]

O Shea S., Cordery M., Barrett W.Y., Richman D.D., Bradbeer C., Batnavala J.E., Hiv excretion patterns and specific antibody responses in body fluids, J Med Virol, 31, pp. 291-296, (1990)

[5]

Belec L., Georges A.J., Steenman G., Martin P., Antibodies to human immunodeficiency virus in vaginal secretion of heterosexual women, J Infect Dis, 160, pp. 385-391, (1989)

[6]

Lu X.S., Belec L., Pillot J., Anti-gpl60 igg and iga antibodies associated with a large increase in total igg in cervicovaginal secretions from human immunodeficiency virus type 1-infected women, J Infect Dis, 167, pp. 1189-1192, (1993)

[7]

Nishanian P., Huskins K.R., Stehn S., Detels R., Fahey J.L., A simple method for improved assay demonstrates that hiv p24 antigen is present as immune complexes in most sera from hiv-infected individuals, J Infect Dis, 162, pp. 21-28, (1990)

[8]

Barr C.E., Miller L.K., Lopez M.R., Et al., Recovery of infectious hiv-1 from whole saliva, J am Dent Assoc, 123, pp. 37-45, (1992)

[9]

Holmstrom P., Syrjanen S., Laine P., Suni J., Hiv antigens detected in gingival fluid [letter], AIDS, 6, pp. 738-739, (1992)

[10]

Anderson D.J., O Brien T.R., Politch J.A., Et al., Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen, JAMA, 267, pp. 2769-2774, (1992)

← 1 2 →